China Colorectal Cancer Treatment Market Overview: 2022-28

Base Year: 2021

Historical Years: 2017-20

Forecast Years: 2022-27

The China Colorectal Cancer Treatment Market is expecting around 3.5% CAGR during 2022-27. The growth of the market is driven primarily by the rising instances of colorectal cancer among people across China, coupled with the mounting consumer awareness about constant innovations in its treatment & diagnosis. 

Markntel Advisor’s China Colorectal Cancer Treatment Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, China Colorectal Cancer Treatment Market drivers, barriers, China Colorectal Cancer Treatment Market Trends, and Key Players in China Colorectal Cancer Treatment Market.

Download a sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/china-colorectal-cancer-market.html

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

China Colorectal Cancer Treatment Market (2022-27): Segmentation Outlook

The market report has segmented the market into the following categories:

·       By Diagnosis

o   Digital Rectal Examination

o   Fecal Occult Blood Test

o   Flexible Sigmoidoscopy

o   Colonoscopy

o   Virtual Colonoscopy

o   Double Contrast Barium Enema

Browse Full Report with Detail Analysis - https://www.marknteladvisors.com/research-library/china-colorectal-cancer-market.html

·       By Treatment

o   Immunotherapy Drugs

§  Monoclonal antibodies

·       Bevacizumab

·       Cetuximab

·       Panitumumab

§  Biologic Response Modifiers

§  Colony-Stimulating Factors

§  Tumor Vaccines

o   Targeted Therapies

o   Chemotherapy

§  Alkylating agent

§  Antimetabolites

·       Fluorouracil

·       Capecitabine

§  Others

o   Surgery

o   Radiation Therapy

According to report, Surgeries are the most common CRC treatment methods practiced to date.

·       By Region

o   North

o   North-East

o   North-West

o   East

o   South-West

o   South Central

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the China Colorectal Cancer Treatment Market:

• Amgen China
• Bristol-Myers Squibb
• Bayer AG
• Merck KGaA
• Roche (China) Co., Ltd.
• Eli Lilly and Company
• Sanofi China
• Taiho Pharmaceutical
• Novartis AG
• Pfizer Inc.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India